Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 14, 2009Alimentary Pharmacology & TherapeuticsOpen Access

Evaluation of the meaningfulness of health‐related quality of life improvements as assessed by the SF‐36 and the EQ‐5D VAS in patients with active Crohn’s disease

View Full Paper
Ask AI
Bookmark
Share

Authors

GCG. CoteurUniversité Libre de BruxellesBrian G. FeaganBrian G. FeaganSemmelweis UniversityDKDorothy L. KeiningerNovartis (Switzerland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Coteur et al. (2009) studied this question.

synapsesocial.com/papers/6a744acbae9b0728cddb5e8bhttps://doi.org/10.1111/j.1365-2036.2009.03966.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group1994 · 125 citations
  2. 2Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis2000 · 509 citations
  3. 3Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities2001 · 783 citations